VIGOUR trials

The VIGOUR group is an international partnership for sharing information, resources, responsibility and credit.

VIGOUR (the Virtual Coordinating Center for Global Collaborative Cardiovascular Research) is an international collaboration of investigators from academic institutions in over 40 countries undertaking clinical trials on treatment for acute cardiovascular events, such as myocardial infarction and stroke.

Official Title

Conditions

Study Type

Study Design

Further Details

VIGOUR (the Virtual Coordinating Center for Global Collaborative Cardiovascular Research) is an international collaboration of investigators from academic institutions in over 40 countries undertaking clinical trials on treatment for acute cardiovascular events, such as myocardial infarction and stroke.The CTC is part of VIGOUR. It works according to the following principles for collaboration:- organisations are self-sufficient, yet working collaboratively- any investigator or any group can take the lead in a clinical trial- each organisation maintains sufficient relevant expertise- groups have compatible systems and accountability to each other for quality production- common site data and site descriptors are used across the whole collaboration- all groups use standard operating procedures for data management, monitoring, audit and biostatistics.The CTC has contributed to the now-completed GUSTO-I and GUSTO-II, SYMPHONY and 2nd SYMPHONY, PARAGON-B and HERO-2 trials.

Study Start

Eligibility & Criteria

Total Enrolment

Contact Details